Feature Channels: OBGYN

Filters close
Released: 28-Mar-2017 11:00 AM EDT
Insurance Coverage for IVF Increases Chance of Having Baby
Washington University in St. Louis

Women who pursue in vitro fertilization (IVF) to become pregnant are more likely to give birth if they have health insurance that covers the procedure, according to new research at Washington University School of Medicine in St. Louis. The key reason is financial rather than medical: For many people, the high cost for one IVF procedure prohibits women from seeking a second treatment if the first attempt fails. The study is published March 28 in The Journal of the American Medical Association.

Released: 28-Mar-2017 10:05 AM EDT
“Substantial” Room for Improvement in HPV Vaccination Coverage, Study Finds
Yale Cancer Center/Smilow Cancer Hospital

While an HPV vaccine became available over 10 years ago, a study led by the Yale School of Public Health finds that there is “substantial” room for improvement in the way it is recommended and discussed.

Released: 27-Mar-2017 1:05 PM EDT
Mobile Technology Shakes Up Pregnancy Research
Scripps Research Institute

Current pregnancy recommendations don’t work for everyone. Researchers at TSRI and STSI aim to change that.

Released: 27-Mar-2017 1:05 PM EDT
NIH Grant Will Further Investigation of Breast Tumor Margin Assessment
University of Arkansas, Fayetteville

The National Institutes of Health has awarded a three-year, $424,081 grant to Magda El-Shenawee, electrical engineering professor, for her work on an intraoperative and rapid method of detecting positive cancer margins during conservative breast cancer surgery, or lumpectomy.

25-Mar-2017 11:00 AM EDT
Study Provides Path for New Immunotherapy Approaches to Prostate Cancer
University of Texas MD Anderson Cancer Center

Prostate cancer, notoriously resistant to immunotherapy due to its immunologically cool nature, triggers two pathways to chill an immune attack after one immunotherapy drug fires up the immune system, researchers at The University of Texas MD Anderson Cancer Center report in Nature Medicine.

Released: 24-Mar-2017 10:05 AM EDT
Nanoparticle Paves the Way for New Triple Negative Breast Cancer Drug
Queen's University Belfast

A potential new drug to tackle the highly aggressive ‘triple negative’ breast cancer – and a nanoparticle to deliver it directly into the cancer cells – has been developed by UK researchers.

21-Mar-2017 10:05 AM EDT
A New Approach to Target an ‘Undruggable’ Prostate Cancer Driver
Michigan Medicine - University of Michigan

When small-molecule inhibitors proved elusive, researchers developed a novel strategy: Using large molecule peptides to target a common prostate cancer driver. It may provide a path for developing new therapies against a challenging target.

Released: 23-Mar-2017 10:05 AM EDT
Virtual Environment Education Reduces Anxiety Prior to Radiation Therapy in Prostate Cancer Patients
Thomas Jefferson University

Radiation therapists and physicians know that education can reduce anxiety before radiation treatment but lack a standardized tool. In an effort to solve this problem, a multidisciplinary team from Jefferson College of Health Professions and the Sidney Kimmel Cancer Center at Thomas Jefferson University conducted a pilot study to see if a virtual environment education program could reduce some of the anxiety their patients face. They published their results in the Journal of Radiation Oncology.

Released: 21-Mar-2017 1:00 PM EDT
New Study: Pre-Pregnancy BMI Directly Linked to Excess Pregnancy Weight Gain
Michigan Medicine - University of Michigan

It’s well known that excessive weight gain during pregnancy can have a lasting negative impact on the health of a mother and her baby. A new University of Michigan-led study finds that for young mothers (women who gave birth between the ages of 15 and 24), pre-pregnancy body mass index, or BMI, and ethnicity might signal a likelihood for obesity later in life.

17-Mar-2017 1:30 PM EDT
New Insights Into Side Effects Can Help Prostate Cancer Patients Choose Treatments
University of North Carolina Health Care System

A new study led by UNC Lineberger Comprehensive Cancer Center researchers identifies distinct patterns of side effects for prostate cancer treatments that patients could use to guide their choices.

20-Mar-2017 2:05 PM EDT
Active Surveillance Preserves Quality of Life for Prostate Cancer Patients
Vanderbilt University Medical Center

Faced with the negative quality-of-life effects from surgery and radiation treatments for prostate cancer, low risk patients may instead want to consider active surveillance with their physician, according to a study released Tuesday by the Journal of the American Medical Association (JAMA).

9-Mar-2017 3:05 PM EST
Combination Immunotherapy Effective for Advanced Prostate Cancer
University of Texas MD Anderson Cancer Center

Researchers at The University of Texas MD Anderson Cancer Center developed a novel chimeric mouse model to test the combination therapy using immune checkpoint blockades with therapies targeting myeloid-derived suppressor cells (MDSCs).

Released: 20-Mar-2017 11:05 AM EDT
Researchers Discover Key to Drug Resistance in Common Breast Cancer Treatment
Scripps Research Institute

Scientists from the Florida campus of The Scripps Research Institute (TSRI), the University of California (UC), San Diego and the University of Illinois have found that two immune system molecules may be key to the development of drug resistance in estrogen-driven breast cancers.

Released: 20-Mar-2017 9:00 AM EDT
Pivotal Trial Begins for Breast Fibroadenoma Using Focused Ultrasound
Focused Ultrasound Foundation

Patients with benign breast tumors may be eligible for a new focused ultrasound–based investigational treatment as part of a pivotal, multi-center clinical study. The trial began last month at the University of Virginia (UVA) Medical Center.

Released: 16-Mar-2017 3:05 PM EDT
Yale Study Published in JNCCN Uncovers Racial Disparities in Treatment of Women with Breast Cancer
Yale Cancer Center/Smilow Cancer Hospital

The study, “Racial and Ethnic Disparities in Oncotype Dx™ Test Receipt in a State-Wide Population-Based Study,” led by Cary P. Gross, MD, Yale University School of Medicine and a member of Yale Cancer Center, is published in the March issue of JNCCN – Journal of the National Comprehensive Cancer Network.

Released: 16-Mar-2017 1:05 PM EDT
Tulane Researcher Awarded $1.9 Million to Improve Menopausal Hormone Therapy
Tulane University

New research at the Tulane University School of Medicine is looking at an estrogen receptor that could be a site for targeted hormone replacement therapy in post-menopausal women.

Released: 16-Mar-2017 12:05 PM EDT
Prostate Cancer Clinical Trial Shows Treating with Precision Radiotherapy Reduces Course of Treatment by 50%
University Health Network (UHN)

An Ontario-led international clinical trial with 1,206 men with localized prostate cancer shows that compressing radiation treatments into four weeks from eight delivers similar outcomes.

Released: 15-Mar-2017 4:05 PM EDT
Study Links Exposure to Common Chemicals During Early Pregnancy to Altered Hormone Levels in Fetus
Seattle Children's Hospital

Food is the most likely source of exposure to the most harmful phthalates, which can also be found in household and personal care products.Exposure during early pregnancy to some phthalates—man-made chemicals commonly found in household plastics, food and personal care products—can have adverse impacts on developing fetuses, according to a new study led by Dr.

Released: 15-Mar-2017 1:30 PM EDT
Yale Study Published in JNCCN Uncovers Racial Disparities in Treatment of Women with Breast Cancer
National Comprehensive Cancer Network® (NCCN®)

Researchers at Yale Cancer Center/Smilow Cancer Hospital found that black and Hispanic women in Connecticut are significantly less likely to undergo gene expression profiling than white women.

Released: 15-Mar-2017 10:05 AM EDT
More IV Fluids, Fewer C-Sections
Thomas Jefferson University

By pooling the data of several studies, Thomas Jefferson University researchers showed that a higher rate of IV fluids not only decreased C-section rates, but also shortened the overall length of labor by one hour, as well as shortened the pushing phase. The results were published online as an accepted article in Acta Obstetricia et Gynecologica Scandinavica.

Released: 14-Mar-2017 4:05 PM EDT
Study Finds No Benefit, but Possible Harm, From Drug Used to Prevent Preterm Births
UT Southwestern Medical Center

A drug commonly prescribed to pregnant women with a history of delivering babies early provides no benefit. In fact, this drug may even increase the risk of developing gestational diabetes.

9-Mar-2017 2:05 PM EST
Reducing Radiation Could Safely Cut Breast Cancer Treatment Costs
Duke Health

More than half of older women with early stage breast cancer received more radiation therapy than what might be medically necessary, adding additional treatment and health care costs, according to a study led by Duke Cancer Institute researchers.

Released: 14-Mar-2017 1:40 PM EDT
Community Collaborators Digging Deeper to Solve High Infant Mortality
Magee-Womens Research Institute

Between 2008 and 2012, 434 infants died in Allegheny County within their first year, ranking the county slightly worse than the national average. While blacks make up only 13.2% of the Allegheny County’s population, black infant deaths over a four-year period constituted 42% (225) of all infant deaths. This racial disparity in the infant mortality rate is 27 percent larger in Allegheny County compared to the national rate.

Released: 14-Mar-2017 12:40 PM EDT
Low Levels of ‘Anti-Anxiety’ Hormone Linked to Postpartum Depression
Johns Hopkins Medicine

In a small-scale study of women with previously diagnosed mood disorders, Johns Hopkins researchers report that lower levels of the hormone allopregnanolone in the second trimester of pregnancy were associated with an increased chance of developing postpartum depression in women already known to be at risk for the disorder.

9-Mar-2017 11:05 AM EST
Two Common Tests Aren’t Effective in Predicting Premature Births, According to New National Study
University of Utah Health

Two screening tests often used to try to predict which pregnant women are likely to deliver prematurely aren’t effective in low-risk women, according to a national collaborative study of more than 10,000 women, led by clinician-researchers at University of Utah Health Sciences and Intermountain Healthcare. Researchers found that neither transvaginal cervical measurement or fetal fibronectin tests, used separately or together, adequately predicts preterm birth. The findings are published in March 14 issue of the Journal of the American Medical Association.

Released: 14-Mar-2017 10:05 AM EDT
For Surgeons in the OR, a Way to Fight Bad Posture
University at Buffalo

Surgeons face psychological stress. Less understood is the physical stress they endure from spending hours in awkward positions in the operating room. This causes shoulder, neck and lower back pain — ailments that lead to sick days, decreased quality of care and early retirements. Researchers are developing a tool to identify poor posture and, ultimately, correct these awkward positions in the operating room.

Released: 14-Mar-2017 8:00 AM EDT
Experts Find Strong Case for Over-the-Counter Oral Contraceptives for Adults and Teens
Johns Hopkins Medicine

After reviewing decades of published studies, a team of pediatric, adolescent and women's health experts concludes that regulatory, behavioral and scientific evidence supports switching oral contraceptives from prescription-only status to over-the-counter (OTC) availability.

13-Mar-2017 10:00 AM EDT
Enlarged Prostate Later in Life Could Stem From Fetal Development Early On
Michigan State University

New research from Michigan State University indicates that embryonic tissue, key to the development of a baby’s gender, could contribute to an enlarged prostate, or BPH, in men later in life.

Released: 13-Mar-2017 11:05 AM EDT
University of Birmingham Study Finds New Class of Androgens Play Key Role in Polycystic Ovary Syndrome
University of Birmingham

Scientists led by the University of Birmingham have discovered that a new class of male sex hormones known as androgens plays a key role in the development of polycystic ovary syndrome (PCOS).

Released: 10-Mar-2017 3:05 PM EST
Castration-Resistant Prostate Cancer Cell Growth Impeded by Endostatin
University of Alabama at Birmingham

Endostatin, a naturally occurring protein in humans, can significantly decrease proliferation of castration-resistant prostate cells in culture, and researchers describe the physiological pathways and signaling evoked by endostatin.

Released: 10-Mar-2017 1:05 PM EST
Mayo Breast Cancer Study Provides Critical Information on Tumor Sequencing and Response to Chemotherapy
Mayo Clinic

Tumor sequencing is increasingly used to select treatment for patients with cancer, but its role in women with newly diagnosed breast cancer is unknown. Mayo Clinic researchers reported the results of a prospective tumor sequencing study in women receiving chemotherapy prior to breast surgery.

7-Mar-2017 8:45 AM EST
Study Describes Potential Clinical Test and Treatment for Preterm Birth
Cincinnati Children's Hospital Medical Center

Scientists identified a molecular driver of inflammation that may finally answer a key question about what causes mild systemic prenatal infections to trigger preterm birth. The finding is an important step to developing a treatment or clinical test for early detection of an entrenched global health problem, according to researchers at Cincinnati Children’s Hospital Medical Center, who report their data March 9 in The Journal of Clinical Investigation Insight (JCI Insight).

Released: 9-Mar-2017 1:05 PM EST
Potential Drug Candidates Halt Prostate and Breast Cancer Growth
Scripps Research Institute

Scientists on the Florida campus of The Scripps Research Institute (TSRI) have designed two new drug candidates to target prostate and triple negative breast cancers.

Released: 9-Mar-2017 10:05 AM EST
Hair Loss and Prostate Drugs Linked to Persistent Erectile Dysfunction in Men
Northwestern University

Men with longer exposure to the drugs finasteride and dutasteride had a higher risk of getting persistent erectile dysfunction than men with less exposure, reports a new study. The persistent erectile dysfunction continued despite stopping these drugs, in some cases for months or years. Prior to the study, there was no strong evidence the drugs cause sexual problems that continue after men stop taking them or that taking these drugs for a longer time increases the chance of experiencing sexual problems.

9-Mar-2017 5:00 PM EST
Vanderbilt Study Shows Early Pregnancy Awareness May Be Key Public Health Strategy
Vanderbilt University Medical Center

The study, “Pregnancy Intention and Maternal Alcohol Consumption,” found that the vast majority of women with intended as well as unplanned pregnancies either stopped or decreased drinking after having a positive pregnancy test.

Released: 8-Mar-2017 4:05 PM EST
Hackensack Meridian Health Now the Only Provider to Offer Advanced Technology to Target Breast Tumors in Monmouth and Ocean Counties
Hackensack Meridian Health

Surgeons and radiologists at four hospitals in coastal New Jersey are among an elite few to use the SAVI SCOUT® surgical guidance system.

8-Mar-2017 10:00 AM EST
Study: Hormone Replacement Therapy May Help Improve Women’s Heart Health, Overall Survival
Cedars-Sinai

Hormone replacement therapy has long been controversial as studies have associated it with health benefits and risks. While some studies suggest that it lowers the risk of osteoporosis and improves some aspects of heart health, others link it to higher risk of cancer and stroke. Now, a new imaging study by investigators at Cedars-Sinai, suggests that women using hormone replacement therapy to relieve menopause symptoms face a lower risk of death and show lower levels of atherosclerosis compared to women who do not use hormone therapy.

Released: 8-Mar-2017 11:05 AM EST
Boosting Communication Is Key in Managing Menopause
University of Delaware

University of Delaware researchers reviewed previous studies about how women manage menopause symptoms and found they often use alternative treatments. But they often do not inform their doctors about them. The UD study aims to open lines of communication between healthcare providers and patients.

Released: 8-Mar-2017 11:05 AM EST
Women More Likely to Follow Through with Breast Screening Recommendations When Informed Directly
University of Colorado Cancer Center

Women at high risk for breast cancer who received a letter informing them of their options for additional imaging with contrast-enhanced MRI of the breast (in addition to a letter sent to their primary care physician) were more likely to return to the center for additional screening with MRI.

Released: 7-Mar-2017 4:05 PM EST
The College of American Pathologists Invites Public Comment on Guideline
College of American Pathologists (CAP)

The College of American Pathologists Invites Public Comment on Guideline for Quantitative Image Analysis (QIA) of HER2 Immunohistochemistry (IHC) for Breast Cancer

7-Mar-2017 10:30 AM EST
Ovarian Cancer Researchers Identify Biomarker Linked to Prognosis in Aggressive Disease Type
University Health Network (UHN)

Ovarian cancer researchers have identified a protein biomarker expressed on the surface of tumour cells in high-grade serous ovarian cancer, the most common and lethal subtype of the disease.

3-Mar-2017 10:05 AM EST
Mom's Weight in Early Pregnancy Associated with Child's Cerebral Palsy
University of Michigan

Being overweight or obese during pregnancy increases the chance of having a child with cerebral palsy, according to new research led by the University of Michigan School of Public Health and the Karolinska Institute in Sweden.

Released: 3-Mar-2017 11:05 AM EST
Michigan Medicine Opens First Prostate Cancer Risk Clinic in the Nation
Michigan Medicine - University of Michigan

The clinic will help men with genetic predisposition to prostate cancer identify and monitor their risk of the disease.

Released: 2-Mar-2017 2:05 PM EST
Surviving Prostate Cancer Through Advanced Diagnostics and Robot-Assisted Technology
NYU Langone Hospital - Brooklyn

Marc Bjurlin, DO, (right) director of urologic oncology at NYU Lutheran Medical Center, used state-of-the-art technology to help patient Mikhail Kurbesov beat prostate cancer.

Released: 2-Mar-2017 2:05 PM EST
Cows May Offer Clues to Improving Fertility in Women
Michigan State University

A Michigan State University researcher has received a $1.65 million grant that looks to bring a better understanding about fertility treatments in women by studying the effect of hormones on ovulation and reproduction in cows.

Released: 1-Mar-2017 3:05 PM EST
Ovarian Cancer Target Molecule May Be Key to Blocking Its Spread
University of Illinois Chicago

Blocking a protein found on the surface of ovarian cancer cells could prevent or reduce the spread of the disease to other organs, according to new research at the University of Illinois at Chicago.

Released: 1-Mar-2017 11:05 AM EST
Women Need to Be Empowered to Take on Shared Decision-Making for Breast Cancer Treatment
Leeds Beckett University

Most women want to be involved in shared decision-making with oncologists when faced with treatment decisions for breast cancer, a new study from Leeds Beckett University has found.



close
1.93308